Can-Fite BioPharma Ltd. SEC filings CANF
Can-Fite BioPharma Ltd. has 865 filings in SEC EDGAR's recent list, going back to Dec 1, 2011. Its latest annual report, Form 20-F, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 2, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Jun 8, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 4, 2026 |
| 3 | Initial insider ownership | Apr 23, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Apr 6, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 23, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 16, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 11, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 4, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 16, 2021 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 9, 2021 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 29, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Jun 19, 2020 | — |
| SC 13G | Ownership over 5% (passive) | Jun 19, 2020 | — |
| SC 13G | Ownership over 5% (passive) | Feb 20, 2020 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2020 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 11, 2020 | — |
| SC 13G | Ownership over 5% (passive) | Jan 31, 2020 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 8, 2020 | — |
| SC 13D/A | Amended ownership over 5% (active) | Oct 24, 2019 | — |
| SC 13D/A | Amended ownership over 5% (active) | Oct 17, 2019 | — |
| SC 13D/A | Amended ownership over 5% (active) | Sep 11, 2019 | — |
| SC 13D/A | Amended ownership over 5% (active) | Aug 8, 2019 | — |
| SC 13D/A | Amended ownership over 5% (active) | Jul 10, 2019 | — |
| SC 13D/A | Amended ownership over 5% (active) | Jun 14, 2019 | — |
| SC 13D/A | Amended ownership over 5% (active) | Jun 6, 2019 | — |
| SC 13G | Ownership over 5% (passive) | May 30, 2019 | — |
| SC 13D | Ownership over 5% (active) | May 30, 2019 | — |
| SC 13G | Ownership over 5% (passive) | May 22, 2019 | — |
| SC 13G/A | Amended ownership over 5% (passive) | May 13, 2019 | — |
| SC 13G | Ownership over 5% (passive) | Apr 12, 2019 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Mar 19, 2019 | — |
| SC 13G | Ownership over 5% (passive) | Feb 4, 2019 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 22, 2019 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 4, 2019 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 3, 2019 | — |
| SC 13G | Ownership over 5% (passive) | Mar 13, 2018 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2018 | — |
| SC 13D/A | Amended ownership over 5% (active) | Nov 21, 2017 | — |
| SC 13D/A | Amended ownership over 5% (active) | May 22, 2017 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 10, 2017 | — |
| SC 13D/A | Amended ownership over 5% (active) | Nov 16, 2016 | — |
| SC 13D/A | Amended ownership over 5% (active) | Sep 21, 2016 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 19, 2016 | — |
| SC 13G | Ownership over 5% (passive) | Feb 12, 2016 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 14, 2016 | — |
| SC 13G | Ownership over 5% (passive) | Sep 28, 2015 | — |
| SC 13G | Ownership over 5% (passive) | Sep 25, 2015 | — |
| SC 13G | Ownership over 5% (passive) | Dec 5, 2014 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2014 | — |
| SC 13D/A | Amended ownership over 5% (active) | May 21, 2013 | — |
| 5 | Annual insider ownership | May 14, 2013 | Dec 31, 2012 |
| 3/A | Primary document | May 14, 2013 | Nov 21, 2011 |
| SC 13D | Ownership over 5% (active) | Dec 2, 2011 | — |
| 3 | Initial insider ownership | Dec 1, 2011 | Nov 21, 2011 |
Showing 63 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CANF (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Ramat Gan, Israel
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1536196
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.